Aventis
May 18, 2012 at 12:58 | Source: Moneycontrol.com
May 16, 2012 at 16:33 | Source: PTI
May 04, 2012 at 12:43 | Source: Moneycontrol.com
Apr 13, 2012 at 18:15 | Source: CNBC-TV18
Apr 10, 2012 at 11:27 | Source: Moneycontrol.com
News across the web »
May 19, 2012 at 22:41 | Source: The Hindu BusinessLine
May 19, 2012 at 02:01 | Source: Business Standard
May 19, 2012 at 00:23 | Source: Business Standard
May 17, 2012 at 02:41 | Source: Business Standard
May 16, 2012 at 20:44 | Source: The Hindu BusinessLine
Interact & exchange stock tips & market info »
Related News »
HONG KONG May 24 (Reuters) - Sanofi-Aventis plans to begin testing a novel compound that is designed to starve liver cancer to death in a phase one human clinical trial in China and possibly South Korea in 2013. The compound, called slit-trap ...
May 24, 2012 at 09:02 | Source: Reuters
Sanofi-Aventis (NYSE:SNY) is one of today's biggest movers, down 1.9% to $34.26. The S&P is currently trading 1.3% lower to 1,300 and the Dow Jones Industrial Average is trading 1.3% lower to 12,343. Sanofi-Aventis is a global pharmaceutical company that ...
May 23, 2012 at 14:54 | Source: Financial News Network Online
Sanofi Group's listed entity in India, today announced that the Registrar of Companies had approved the company's change of name from Aventis Pharma Ltd to 'Sanofi India Ltd', with effect from May 11. The shareholders of the company had earlier ...
May 16, 2012 at 11:14 | Source: MoneyControl.com
New York, May 18th (TradersHuddle.com) - Sanofi-Aventis (NYSE:SNY) closed the trading session at $34.29, near its 200 day moving average set at $35.74. Sanofi-Aventis' stock action is below this level, which makes the stock difficult to be bought, as it ...
May 18, 2012 at 09:38 | Source: TradersHuddle.com
New York, May 16th (TradersHuddle.com) - Shares of Sanofi-Aventis (NYSE:SNY) closed the trading session at $34.60 below calculated support at $35.59. The stock broke down technically, raising concerns as the move might trigger additional selling.
May 16, 2012 at 12:25 | Source: TradersHuddle.com
Thursday, May 17, 2012... Sanofi Aventis (NYSE:SNY) closed Wednesday's reticent trading session at $34.29. In the past year, the stock has hit a 52-week low of $30.98 and..... Friday, May 11, 2012... Sanofi-Aventis (NYSE: SNY) closed Thursday's trading ...
May 23, 2012 at 12:03 | Source: Market Intelligence Center
Law360, New York (May 21, 2012, 2:05 PM ET) -- Bristol-Myers Squibb Co. and Sanofi-Aventis US LLC on Friday urged a judge to toss a suit accusing the drugmakers of deceptively marketing their blockbuster blood thinner Plavix and causing patients to overpay ...
May 21, 2012 at 18:03 | Source: site.law360.com
Hong Kong - Drug company Sanofi-Aventis plans to begin testing a novel compound that is designed to starve liver cancer to death in a phase one human clinical trial in China and possibly South Korea in 2013. The compound, called slit-trap, was developed by ...
May 24, 2012 at 14:39 | Source: Beeld
The research was supported by the University of Perugia and a grant-in-aid from Bayer HealthCare. Dr. Becattini received an Aventis Fellowship for Clinical Research from the International Society of Thrombosis and Haemostasis. One coauthors reports ...
May 25, 2012 at 21:33 | Source: Medscape News
The case revolves around a Sanofi-Aventis drug, docetaxel, used to treat many forms of cancer. It has the potential to save lives or improve the quality of life of cancer patients, but remains expensive and under patent. The Treatment Action Campaign (TAC ...
May 15, 2012 at 11:22 | Source: Independent Online